ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
SciSparc Ltd

SciSparc Ltd (SPRC)

0.296
-0.0025
(-0.84%)
0.2994
0.0034
(1.15%)

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.2994
Bid
0.29
Ask
0.313
Volume
109,242
0.29 Day's Range 0.314
0.197 52 Week Range 1.79
Market Cap
Previous Close
0.2985
Open
0.3046
Last Trade
18
@
0.3108
Last Trade Time
Financial Volume
$ 32,864
VWAP
0.30084
Average Volume (3m)
2,176,889
Shares Outstanding
10,828,251
Dividend Yield
-
PE Ratio
-0.43
Earnings Per Share (EPS)
-0.69
Revenue
1.31M
Net Profit
-7.47M

About SciSparc Ltd

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The compa... SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Tel Aviv, Center, Isr
Founded
-
SciSparc Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRC. The last closing price for SciSparc was $0.30. Over the last year, SciSparc shares have traded in a share price range of $ 0.197 to $ 1.79.

SciSparc currently has 10,828,251 shares outstanding. The market capitalization of SciSparc is $3.23 million. SciSparc has a price to earnings ratio (PE ratio) of -0.43.

SPRC Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.025-7.70653514180.32440.340.291103400.30924884CS
4-0.0127-4.069208586990.31210.350.2721931350.3173298CS
12-0.0146-4.649681528660.3140.50.22621768890.36943108CS
260.078435.47511312220.2211.790.19762099870.61911867CS
52-0.5906-66.35955056180.891.790.19741043730.57301449CS
156-47.2806-99.370744010147.5871.50.19724761696.7948544CS
260-181.7006-99.8354945055182184.080.19721950689.2712585CS

SPRC - Frequently Asked Questions (FAQ)

What is the current SciSparc share price?
The current share price of SciSparc is $ 0.2994
How many SciSparc shares are in issue?
SciSparc has 10,828,251 shares in issue
What is the market cap of SciSparc?
The market capitalisation of SciSparc is USD 3.23M
What is the 1 year trading range for SciSparc share price?
SciSparc has traded in the range of $ 0.197 to $ 1.79 during the past year
What is the PE ratio of SciSparc?
The price to earnings ratio of SciSparc is -0.43
What is the cash to sales ratio of SciSparc?
The cash to sales ratio of SciSparc is 2.49
What is the reporting currency for SciSparc?
SciSparc reports financial results in USD
What is the latest annual turnover for SciSparc?
The latest annual turnover of SciSparc is USD 1.31M
What is the latest annual profit for SciSparc?
The latest annual profit of SciSparc is USD -7.47M
What is the registered address of SciSparc?
The registered address for SciSparc is 20 RAUL WALLENBERG ST., TOWER A, 2ND FLOOR, TEL AVIV, CENTER, 6971916
What is the SciSparc website address?
The website address for SciSparc is scisparc.com
Which industry sector does SciSparc operate in?
SciSparc operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.359
(-0.09%)
193.97M

SPRC Discussion

View Posts
glenn1919 glenn1919 2 months ago
SPRC............................................a/h
๐Ÿ‘๏ธ0
glenn1919 glenn1919 3 months ago
SPRC....................................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 4 months ago
SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology $SPRC https://t.co/PabDeGg9nf— Life Science Report (@lifesciencerpt) February 18, 2025
๐Ÿ‘๏ธ0
tw0122 tw0122 5 months ago
Regained compliance news .79
๐Ÿ‘๏ธ0
subslover subslover 5 months ago
SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results
TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that MitoCareX Bio Ltd. (โ€œMitoCareXโ€), its joint venture with Dr. Alon Silberman, is expanding its research and development efforts into pancreatic cancer following encouraging initial in-vitro results.

MitoCareX, which focuses on drug discovery and the development of cancer therapeutics targeting the mitochondrial SLC25 protein family, recently achieved positive results using pancreatic cancer cell lines. These findings build on MitoCareXโ€™s earlier success in developing a computationally advanced drug discovery platform that virtually screened millions of small molecules, identifying several as potential anti-cancer treatments.

By leveraging its in-vitro screening systems related to mitochondria, MitoCareX corroborated the anti-cancer biological activity of several small molecule structures discovered out of millions of them that were virtually screened the addition of pancreatic cancer to its existing focus on non-small cell lung cancer marks a significant expansion of its therapeutic ambitions.

Additionally, MitoCareX continues its efforts to create a predictive artificial intelligence (AI) model, utilizing the extensive virtual data generated during its discovery processes. This model is designed to efficiently navigate broader chemical spaces, with the goal of uncovering more novel anti-cancer scaffolds targeting the SLC25 protein family.

Pancreatic cancer remains one of the most aggressive and difficult-to-treat cancers, with a significant unmet medical need. According to the American Cancer Society, the 5-year survival rate for pancreatic cancer is just 12% (as of 2023), one of the lowest among all cancers. It is the third leading cause of cancer-related deaths in the United States.
👍 1
LowFloatLopes LowFloatLopes 5 months ago
Boom! 
👍 1
glenn1919 glenn1919 5 months ago
sprc..........................................................a/h
๐Ÿ‘๏ธ0
subslover subslover 5 months ago
I am pretty sure that the $200 mil PP on CCCC is finally over. 😇
๐Ÿ‘๏ธ0
B RY B RY 5 months ago
Sprc, cccc, and lucy are my main interest currently and possible long term holds. You and I are very familiar with all 3. Time will tell, but I think all 3 will have a good 2025.
๐Ÿ‘๏ธ0
subslover subslover 5 months ago
B RY, hey buddy! Thank you for this info! The company must have finally gotten its act together. I bet we see many more nice PR's🥰
๐Ÿ‘๏ธ0
B RY B RY 5 months ago
My fingers were working faster than my mind. 3/6/2024 was last year's 13g filing, lol. I did my reading about their business collaborations first and like the business model for strong growth. I hold it for awhile and see what develops.
๐Ÿ‘๏ธ0
B RY B RY 5 months ago
Hi subs! I'm in after I checked finviz and saw new insitutional interest(13g) filed today with a nice drop in price from the high this morning.

https://fintel.io/so/us/sprc

๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: And get ready to sell the NEXT half???
๐Ÿ‘๏ธ0
LowFloatLopes LowFloatLopes 5 months ago
Back in 1.22
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: You may have to WAIT quite awhile for THAT price, Homeboy!!! (Maybe like DAYS!!)
๐Ÿ‘๏ธ0
LowFloatLopes LowFloatLopes 5 months ago
I'll be back at $1.28 
๐Ÿ‘๏ธ0
LowFloatLopes LowFloatLopes 5 months ago
Sold other half $1.70
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: RE-launced at 212%!!!
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: 2nd halt at 180%!!!
๐Ÿ‘๏ธ0
LowFloatLopes LowFloatLopes 5 months ago
I sold half at $1.20 
๐Ÿ‘๏ธ0
Mojocash Mojocash 5 months ago
Took profit to early! Best of Luck everyone!
๐Ÿ‘๏ธ0
LowFloatLopes LowFloatLopes 5 months ago
Halt!
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: UN-halted!!! (I want a Planet JUPITER run!!!!)
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 5 months ago
SPRC: Halted.
๐Ÿ‘๏ธ0
subslover subslover 5 months ago
Great job!😷
๐Ÿ‘๏ธ0
Mojocash Mojocash 5 months ago
Great run. Target met. 2 bags.
๐Ÿ‘๏ธ0
subslover subslover 5 months ago
$1.26 on the news. SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today as part of its ongoing collaboration with Clearmind Medicine Inc. (โ€œClearmindโ€) (Nasdaq: CMND) (FSE: CWY0), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, the publication of a European patent application submitted by Clearmind under the European Patent Office for innovative combination therapy of MEAI and N-Acylethanolamines, to binge behavior including alcohol consumption, eating, tobacco consumption, shopping and sexual conduct.

Under this collaboration, SciSparc and Clearmind are researching innovative combination therapies that integrate psychedelic molecules with the N-acylethanolamines family, including Palmitoylethanolamide. To date, thirteen patents related to this collaboration have been filed by Clearmind in the United States as well as in several other global jurisdictions.

About SciSparc Ltd. (Nasdaq: SPRC):

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparcโ€™s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; and SCI-210 for the treatment of autism and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seedsโ€™ oil-based products on the Amazon.com Marketplace.
๐Ÿ‘๏ธ0
glenn1919 glenn1919 5 months ago
SPRC......https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Mojocash Mojocash 5 months ago
Dollar break coming!!!!
๐Ÿ‘๏ธ0
Mojocash Mojocash 6 months ago
Great move on small volume
๐Ÿ‘๏ธ0
glenn1919 glenn1919 6 months ago
SPRC...............https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
tw0122 tw0122 6 months ago
.54
๐Ÿ‘๏ธ0
tw0122 tw0122 6 months ago
Tourette Alzheimer's and Chinese EV imports 

๐Ÿ‘๏ธ0
Mojocash Mojocash 6 months ago
This thing is killing it today from 39. Loving this play.
๐Ÿ‘๏ธ0
glenn1919 glenn1919 6 months ago
SPRC...................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Mojocash Mojocash 6 months ago
A 10.6 mill o/s and trades 230 million and only up 133%. Scratching my head.
๐Ÿ‘๏ธ0
Mojocash Mojocash 6 months ago
This should pop hard... volume is epic
๐Ÿ‘๏ธ0
Mojocash Mojocash 6 months ago
200 million in volume! Should be a lot higher in price..... you'd think....
๐Ÿ‘๏ธ0
subslover subslover 6 months ago
Once a pump = always a pump.😇
๐Ÿ‘๏ธ0
tw0122 tw0122 6 months ago
Looks like pump close to over .72 +'225% from pharma divested to auto imports 
๐Ÿ‘๏ธ0
subslover subslover 6 months ago
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (โ€œAutoMaxโ€), a leading automotive importer and distributor in Israel with which the Company has entered into an agreement and plan of merger, received its first shipment of vehicles manufactured by Anhui Jianghuai Automobile Group Co., Ltd. (โ€œJAC Motorsโ€), a globally recognized Chinese automotive company. This marks a significant milestone in AutoMaxโ€™s direct import and distribution operations, launched under agreements signed earlier this year with JAC Motors.

The shipment follows regulatory approvals for direct importation and positions AutoMax to begin marketing and sales activities for JAC Motors vehicles across Israel.

SciSparc has provided financial support to AutoMax, which SciSparc believes helped provide AutoMax with resources to facilitate the transaction with JAC Motors. Further, as part of its growth strategy, AutoMax entered into a merger agreement with the Company in April 2024, that if completed would pave the way for SciSparcโ€™s expansion into the automotive sector. The merger is subject to closing conditions, including the approval of the shareholders of each of the Company and AutoMax.

About SciSparc Ltd. (Nasdaq: SPRC):
๐Ÿ‘๏ธ0
Awl416 Awl416 9 months ago
Fall for it if ya want

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
SPRC new 52;week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
SPRC new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 9 months ago
SPRC new 52 week low

๐Ÿ‘๏ธ0
Awl416 Awl416 10 months ago
Talk about jumping off a cliffโ€ฆ
๐Ÿ‘๏ธ0
glenn1919 glenn1919 10 months ago
SPRC.............................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Pastor Phil Pastor Phil 10 months ago
Iโ€™m sold out
๐Ÿ‘๏ธ0
webprods webprods 10 months ago
Great news today. 1.63 coming
๐Ÿ‘๏ธ0
webprods webprods 10 months ago
32.63% pm . Actual
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock